Dr. Cadegiani is a leading expert in Endocrinology, Sports Medicine, and Obesity Management. A core contributor to the FLCCC COVID-19 protocols, Dr. Cadegiani has successfully treated thousands of COVID patients in Brazil with few hospitalizations and no deaths.
After attaining his medical degree from the University of Brasilia in 2008, Dr. Cadegiani completed a residency in internal medicine in 2010 and a fellowship in Endocrinology and Metabolism in 2012.
He has conducted extensive research on fatigue-related conditions, ‘hormonal conditioning’, and pharmacological weight loss management, and is the creator of the first scientifically proven effective therapy to prevent bariatric surgery in morbidly obese subjects.
When it comes to COVID-19, Dr. Cadegiani conducted some of the largest clinical trials and observational studies, including the Itajaí ivermectin studies. He is responsible for the first hypothesis that explains the massive number of post-vaccine myocarditis cases and sudden deaths, particularly among young males and athletes.